Close Menu

NEW YORK (GenomeWeb News) – Genometry announced today that it has signed a multi-year deal with Janssen Pharmaceutica to generate gene-expression profiles from 250,000 compounds in Janssen's small-molecule screening library using its L1000 Expression profiling system.

The L1000 is designed to produce high-dimensional, gene-expression profiles from crude cell lysates in a 384-well plate format. The technology was developed at the Broad Institute, MIT, and the Dana-Farber Cancer Institute, and exclusively licensed by Genometry for pharmaceutical applications.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.